Gallus Biopharmaceuticals to Retain/Add 320 Jobs in Missouri
05/22/2011
Recently Gallus purchased the former 15-acre, 200,000-square-foot Centocor Biologics facility in Berkeley. The company plans to make an initial capital investment of $20 million to expand the facility, hire about 160 Centocor employees; and create about 160 new jobs over the next five years. The average salary is expected to be $88,500.
Gallus Biopharmaceuticals is a contract manufacturer of pharmaceuticals produced from cell cultures. It plans on expanding the commercially certified, FDA-approved facilities at the former Centocor plant by building a clinical services suite, expanding the existing development lab and fitting out a commercial suite.
The state of Missouri awarded Gallus a $14.6 million economic incentive package, redeemable over the next 10 years.
Project Announcements
Kimberly-Clark Expands Aiken County, South Carolina, Distribution Operations
05/04/2025
Aerowerks Plans Gaffney, South Carolina, Manufacturing Operations
05/04/2025
Sweden-Based Troax Group Plans Portland, Tennessee, Manufacturing Operations
05/04/2025
Kimberly-Clark Corporation Plans Warren, Ohio, Manufacturing Operations
05/04/2025
Denmark-Based Novonesis Expands Salem, Virginia, Production Operations
05/04/2025
Polyvlies USA Expands Winston-Salem, North Carolina, Manufacturing Operations
05/04/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024